Veegaland Developers opened for subscription on 10 Sept and closes on 15 Sept 2026. GMP is ₹24 (about 17.1% over the cap price).
Veegaland Developers IPO Subscription Status
| Category | Subscribed (times) | Bids received |
|---|---|---|
| QIB | 0.45x | ₹14.42 cr |
| NII (HNI) | 0.39x | ₹9.35 cr |
| Retail | 0.82x | ₹46.50 cr |
| Total | 0.62x | ₹70.27 cr |
Updated through the bidding window; final numbers settle after the issue closes.
Veegaland Developers IPO Day-wise GMP
Latest grey market premium: ₹20 (about 14.3% over the cap price).
| Date | GMP | Est. gain |
|---|---|---|
| 8 September | ₹30 | 21.43% |
| 7 September | ₹30 | 21.43% |
| 4 September | ₹18 | 12.86% |
| 3 September | ₹18 | 12.86% |
| 2 September | ₹18 | 12.86% |
| 1 September | ₹14 | 10.00% |
GMP is unofficial and changes through the day; it is not endorsed by SEBI or the exchanges and should not be the only basis for a decision.
Should You Apply to Veegaland Developers IPO?
As things stand, the grey market premium points to a listing near ₹164 (about 17.1%). In the company's favour: Focuses on high-margin premium and luxe residential segments across Kerala. The main risk to weigh: Business operations and market demand are concentrated entirely within Kerala. Judge the price against the company's earnings and your holding period, not the GMP alone.
How to Apply for Veegaland Developers IPO
- Log in to your broker's IPO section and select Veegaland Developers.
- Bid at the cut-off price for the best chance of allotment (retail).
- Enter the number of lots (minimum 107 shares) and submit your UPI ID.
- Approve the mandate request in your UPI app before the cut-off time to block the funds.
Quick facts: Price band ₹130 – ₹140 · Lot 107 shares (~₹14,980) · Bidding 10 Sept – 15 Sept · Listing 18 Sept on BSE, NSE · Registrar MUFG Intime India Pvt. Ltd.
More on Veegaland Developers IPO
- Veegaland Developers IPO — live GMP, subscription & allotment status
- Veegaland Developers IPO listing gain calculator
- All Mainboard IPOs
- Full IPO list with GMP
This article is for information only and is not investment advice. Read the RHP and consider your own risk profile before investing.
Loading comments...